The chapter examines boardroom dynamics amidst a shareholder activist campaign, discussing underperformance, executive compensations, and the push for change. It also covers financial struggles in the context of weight loss drugs impacting employer costs and the need for wider availability and affordability of medications. The conversation emphasizes the urgency of addressing health issues like obesity and advocates for government intervention to negotiate prices and provide subsidies.
Kara and Scott discuss Disney’s proxy fight with Nelson Peltz nearing an end, a new cap on credit card late fees, and employers dialing back on coverage of weight loss drugs. Also, the Biden-Trump rematch is getting closer after Super Tuesday. Plus, OpenAI intends to dismiss all of Elon Musk’s legal claims and an open letter for “AI for a Better Future.” Then, a listener question about why Siri is so bad.
Follow us on Instagram and Threads at @pivotpodcastofficial.
Follow us on TikTok at @pivotpodcast.
Send us your questions by calling us at 855-51-PIVOT, or at nymag.com/pivot.
Learn more about your ad choices. Visit podcastchoices.com/adchoices